Effectiveness of Pregabalin for Treatment of Burning Mouth Syndrome
Küçük Resim Yok
Tarih
2019
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Korean Coll Neuropsychopharmacology
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Treatment of burning mouth syndrome (BMS) is challenging because there is no consensus regarding pharmalogical or nonpharmalogical therapies. The use of anticonvulsants is controversial. We present nine patients BMS who respond to pregabalin. They were diagnosed secondary BMS except two. Etiologic regulations were made firstly in patients with secondary BMS but symptoms did not decrease. We preferred pregabalin in all patients and got good results. Furthermore the addition of pregabalin to the treatment of two patients who did not respond adequately to duloxetine provided good results. We are only aware that pregabalin may reduce symptoms as a result of case reports. We believe that the diagnosis of pathologic etiology with appropriate diagnostic tests will result in better outcomes in treatment.
Açıklama
Anahtar Kelimeler
Burning Mouth Syndrome, Anticonvulsants, Pregabalin
Kaynak
Clinical Psychopharmacology And Neuroscience
WoS Q Değeri
Q3
Scopus Q Değeri
Q2
Cilt
17
Sayı
1
